The results from AR reporter assays and gene expression analyses of AR target genes in prostate cancer cell lines support the hypothesis that CT7001 represses transcription mediated by both full-length AR and truncated, constitutively active AR-Vs in vitro. The gene discussed is AR; the disease is prostate carcinoma.